2016
Simultaneous whole body 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with 18F-fluorodeoxyglucose positron emission tomography computed tomography
Pugmire B, Guimaraes A, Lim R, Friedmann A, Huang M, Ebb D, Weinstein H, Catalano O, Mahmood U, Catana C, Gee M. Simultaneous whole body 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with 18F-fluorodeoxyglucose positron emission tomography computed tomography. World Journal Of Radiology 2016, 8: 322-330. PMID: 27028112, PMCID: PMC4807342, DOI: 10.4329/wjr.v8.i3.322.Peer-Reviewed Original ResearchPositron emission tomography-computed tomographyDiffusion-weighted imagingMalignant lesionsPediatric oncology patientsPET-MRIMagnetic resonance imagingPositron emission tomographyBenign lesionsPositron emission tomography-computed tomography examinationFDG maximum standardized uptake valueMinimum apparent diffusion coefficientMaximum standardized uptake valueEmission tomography-computed tomographyOncology patientsWhole-body diffusion-weighted imagingHealth Insurance Portability and Accountability Act-compliantStandard department protocolDetection of malignant lesionsEmission tomographyResonance imagingStandardized uptake valuePositron emission tomography magnetic resonance imagingSingle-center studySuspected cancer diagnosisEPI diffusion-weighted imaging
2014
[18F]-Fluoromisonidazole Positron Emission Tomography/Computed Tomography Visualization of Tumor Hypoxia in Patients With Chordoma of the Mobile and Sacrococcygeal Spine
Cheney M, Chen Y, Lim R, Winrich B, Grosu A, Trofimov A, Depauw N, Shih H, Schwab J, Hornicek F, DeLaney T. [18F]-Fluoromisonidazole Positron Emission Tomography/Computed Tomography Visualization of Tumor Hypoxia in Patients With Chordoma of the Mobile and Sacrococcygeal Spine. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: 1030-1036. PMID: 25539367, PMCID: PMC4280072, DOI: 10.1016/j.ijrobp.2014.08.016.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCell HypoxiaChordomaFeasibility StudiesFemaleHumansMaleMiddle AgedMisonidazoleMultimodal ImagingNeoplasm Recurrence, LocalPhotonsPilot ProjectsPositron-Emission TomographyProspective StudiesProton TherapyRadiopharmaceuticalsRadiotherapy DosageRelative Biological EffectivenessSacrococcygeal RegionSpinal NeoplasmsTomography, X-Ray ComputedTumor BurdenConceptsHypoxic subvolumesGross tumor volumeFMISO PET/CTRadiation therapyLocal recurrenceTumor volumeSacrococcygeal spinePositron emission tomography/computed tomographyRT dose escalationStage T2 tumorsEmission tomography/computed tomographyStandardized uptake valueMedian follow-upTreatment of chordomasChanges to treatmentVisualization of tumor hypoxiaDose escalationT2 tumorsTomography/computed tomographyMetastatic diseaseRecurrent chordomaUptake valueClinical characteristicsTumor hypoxiaFollow-up